Genomic prostate score does not improve risk assessment

• Medicine Branch (A-M) / Hematology

Genomic prostate score does not improve risk assessment

A genomic prostate score (GPS) has little value in predicting adverse outcomes in men who have undergone a period of active surveillance before having a radical prostatectomy, according to a study published in the Journal of Clinical of Oncology.The